LONDON, May 8 (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.
from Reuters: New Issues News https://ift.tt/2rr6f4n
Tidak ada komentar:
Posting Komentar